News Archive
If measures to tackle multidrug-resistant tuberculosis (MDR-TB) are not significantly stepped up, including addressing barriers that prevent both research into better drug combinations and treatment scale up, MDR-TB rates will continue to increase worldwide and a historic opportunity to improve abysmal cure rates will have been squandered, medical humanitarian organisation Médecins Sans Frontières warned today.
Nouveau Life Pharmaceuticals Inc., a leading provider of quality all-natural dietary supplements, announced today the release of its newest supplement product: New Life Naturals: For Your Weight Loss.
Human umbilical cord blood cells (HUCB) used to treat cultured rat brain cells (astrocytes) deprived of oxygen appear to protect astrocytes from cell death after stroke-like damage, reports a team of researchers from the University of South Florida (USF) Department of Neurosurgery and Brain Repair.
Findings published in the August 2004 issue of Diabetes Care indicate that a new analytical tool - the Continuous Glucose Error-Grid Analysis (CG-EGA) - which was created to evaluate the clinical accuracy of continuous glucose monitoring in people with diabetes, shows that continuous monitoring can provide highly accurate test results.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, today announced positive preliminary results of a Phase IIa study in inflammatory bowel disease (IBD) with its lead autoimmune compound vidofludimus, an oral inhibitor of interleukin-17 (IL-17) release.
› Verified 4 days ago